[Click here to JOIN and get our WEEKLY newsletter!!]

UM depression center to reach out to students
Detroit News, MI - Aug 12, 2003
... Those were pretty negative feelings for a child," she said. She now
is taking the antidepressant Lexapro, and is seeing a therapist. ...

Not happy pills
The Olympian, WA - Aug 12, 2003
... Some of the most common antidepressants are selective serotonin reuptake inhibitors
(SSRIs), which include Prozac, Paxil, Celexa, Zoloft and Lexapro, Kaufman ...

Forest sees no antidepressant generic before 2011
Forbes - Aug 11, 2003
(nyse: FRX - news - people) said on Monday it does not expect generic competition
for its new depression drug, Lexapro, until 2011 at the earliest, contrary to ...

Challenging ‘ Extreme ’ Shyness
Newsweek - Aug 8, 2003
... in 1999. Other drugs, including Lexapro, may follow. Unlike therapy,
though, relapse can be an issue once treatment stops. And the ...

Forest Laboratories "sector perform"
New Ratings - Aug 8, 2003
In a research note published this afternoon, the analyst mentions that IVAX
Diagnostics has challenged Forest Laboratories’ Lexapro patent. ...

Ivax might get antidepressant earlier than expected
Forbes - Aug 7, 2003
said on Thursday it might have to only wait until 2006 to market a generic version
of Lexapro, a new antidepressant marketed by Forest Laboratories Inc. ...

Ivax says applied for generic version of Lexapro
Forbes - Aug 6, 2003
said on Wednesday it has applied to market a generic version of Lexapro,
an antidepressant marketed by Forest Laboratories Inc. ...

Ivax: We made that filing
South Florida Business Journal, FL - Aug 6, 2003
... speculation arising from a report earlier this week that an unknown company had filed
an application to market a generic version of the depression drug Lexapro ...

IVAX Confirms First to File Generic Submission on Lexapro
Business Wire (press release) - Aug 6, 2003
... of a report earlier this week that an unknown generic company had filed a generic
drug application containing a patent challenge to Forest Laboratories' Lexapro ...

European Stocks Advance as Credit Suisse, Clariant, Rhodia Gain
Bloomberg - Aug 5, 2003
... to 115.5 Danish kroner after Morgan Stanley cut its rating to ``underweight'' from
``equalweight.'' The company may have to defend the patent for Lexapro, its ...

Credit Suisse leads bourses higher, Clariant jumps
Forbes - Aug 5, 2003
... Denmark's pharmaceutical group Lundbeck dropped 3.7 percent to 115.50 Danish crowns,
hit by news of a potential rival to its best-selling antidepressant Lexapro ...

Credit Suisse leads bourses higher, Clariant jumps
Reuters, UK - Aug 5, 2003
... pharmaceutical group Lundbeck LUN.CO dropped 3.7 percent to 115.50 Danish crowns,
hit by news of a potential rival to its best-selling antidepressant Lexapro ...

European Stocks Advance as Credit Suisse, Clariant, Rhodia Gain
Bloomberg - Aug 5, 2003
... The company may have to defend the patent for its newest antidepressant, Lexapro,
in the US An unidentified company is challenging a patent on versions of ...

Credit Suisse leads bourses higher, Clariant jumps
Reuters, UK - Aug 5, 2003
... pharmaceutical group Lundbeck LUN.CO dropped 3.7 percent to 115.50 Danish crowns,
hit by news of a potential rival to its best-selling antidepressant Lexapro ...

European Stocks Gain as Credit Suisse, Aegon, Clariant Advance
Bloomberg - Aug 5, 2003
... The company may have to defend the patent for its newest antidepressant, Lexapro,
in the US An unidentified company is challenging a patent on versions of ...

European Stocks Climb; Credit Suisse, Aegon and Clariant Rise
Bloomberg - Aug 5, 2003
... The company may have to defend the patent for its newest antidepressant, Lexapro,
in the US An unidentified company is challenging a patent on versions of ...

Navy Officially OKs Northrop Dea
Newsday - Aug 5, 2003
... Forest Laboratories Inc., the drugmaker that focuses on treating mental disorders,
may have to defend its patent for the antidepressant Lexapro after receiving ...

Navy Officially OKs Northrop Dea
Newsday - Aug 5, 2003
... Forest Laboratories Inc., the drugmaker that focuses on treating mental disorders,
may have to defend its patent for the antidepressant Lexapro after receiving ...

European Stocks Climb; Shares of Credit Suisse, Aegon Advance
Bloomberg - Aug 5, 2003
... The company may have to defend the patent for its newest antidepressant, Lexapro,
in the US An unidentified company is challenging a patent on versions of ...

European Stocks Climb; Shares of Credit Suisse, Aegon Advance
Bloomberg - Aug 5, 2003
... The company may have to defend the patent for its newest antidepressant, Lexapro,
in the US An unidentified company is challenging a patent on versions of ...

Compulsive shopper? There's now a pill
Jewish World Review - Aug 1, 2003
... to shop nearly disappeared. She now has a prescription for a drug called
Lexapro, which was derived from citalopram. "I've had such ...

Drug may help curb urge to shop compulsively
San Jose Mercury News, CA - Aug 1, 2003
... to shop nearly disappeared. She now has a prescription for a drug
called Lexapro, which was derived from citalopram. ``I've had ...

Antidepressant shows promise as cure for compulsive shopping
Centre Daily Times, PA - Jul 31, 2003
... to shop nearly disappeared. She now has a prescription for a drug called
Lexapro, which was derived from citalopram. "I've had such ...

Schaeffer's Option Activity Watch Features FRX, TXN, WFC
Yahoo News (press release) - Jul 24, 2003
... 15, meeting the Street estimate. FRX cited strength in sales of its
anti-depressants Celexa and Lexapro. However, it warned that ...

FOREST REPORTS Q1 EARNINGS GROWTH, WARNS MAY MISS FY EPS TARGET
Pharmexec (press release) - Jul 23, 2003
... Lexapro (escitalopram) amassed quarterly sales totaling $191 million, offsetting
declining sales of Forest’s older product, Celexa (citalopram), which had ...